Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here